A Sustainable Writing Instrument Using Biodegradable PHA-Starch Polymers and Pollution-Derived Carbon Ink
International Journal of Innovative Science and Research Technology · 06.03.2026 · 2639
DOI: 10.38124/ijisrt/26feb1265 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Innovative Science and Research Technology, online erschienen am 06.03.2026. Verfasst von Kavya Sudha Bolla. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
This article explores a novel approach to sustainable writing instruments by combining two eco-innovations: a biodegradable pen body made from a PHA starch plastic blend and ink derived from carbon waste captured from pollution sources. Unlike prior efforts, where soot-based pigments required mixing with water for paint-like applications, this concept uses a safe, child-friendly polyol-based carrier system (propylene glycol, glycerin, PEG-400) to produce ink with the same texture and flow as everyday pen inks. The project highlights material selection, chemical safety, purification workflows, and the engineering of a refillable prototype. It bridges three perspectives: electrical and electronic systems thinking, material science, and sustainability impact.
Zitieren
APA
Bolla, K. S. (2026). A Sustainable Writing Instrument Using Biodegradable PHA-Starch Polymers and Pollution-Derived Carbon Ink. International Journal of Innovative Science and Research Technology, 2639. https://doi.org/10.38124/ijisrt/26feb1265
Vancouver
Bolla KS. A Sustainable Writing Instrument Using Biodegradable PHA-Starch Polymers and Pollution-Derived Carbon Ink. International Journal of Innovative Science and Research Technology. 2026:2639. doi:10.38124/ijisrt/26feb1265
BibTeX
@article{Bolla2026,
author = {Bolla, Kavya Sudha},
title = {A Sustainable Writing Instrument Using Biodegradable PHA-Starch Polymers and Pollution-Derived Carbon Ink},
journal = {International Journal of Innovative Science and Research Technology},
year = {2026},
pages = {2639},
doi = {10.38124/ijisrt/26feb1265}
}
EUVIMED